Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Culakova

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Cancer|August 21, 2007
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapyMichelle Shayne, Eva Culakova, Marek S Poniewierski, et al.
Cancer|August 13, 2009
Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapyMichelle Shayne, Eva Culakova, Debra Wolff, et al.
Journal of Geriatric Oncology|January 30, 2014
Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignanciesMichelle Shayne, Eva Culakova, Marek S Poniewierski, et al.
Frontiers in Nutrition|April 5, 2024
Changes in the consumption of isoflavones, omega-6, and omega-3 fatty acids in women with metastatic breast cancer adopting a whole-food, plant-based diet: post-hoc analysis of nutrient intake data from an 8-week randomized controlled trialJean Lee, Erin K Campbell, Eva Culakova, et al.
Pharmacoeconomics|April 4, 2007
Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspectiveLeon E Cosler, Adi Eldar-Lissai, Eva Culakova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2008
Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practiceJeffrey Crawford, David C Dale, Nicole M Kuderer, et al.
Journal of Geriatric Oncology|November 26, 2024
Designing observational studies to estimate treatment effects in geriatric oncology: A closer look at confounding and its mitigationNienke A de Glas, Sophie Pilleron, Esther Bastiaannet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic reviewGary H Lyman, David C Dale, Debra A Wolff, et al.
Cancer|April 22, 2011
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapyGary H Lyman, Nicole M Kuderer, Jeffrey Crawford, et al.
The Oncologist|September 20, 2025
Effect of a whole food plant-based dietary intervention on cancer progression and inflammatory markersKatherine K S Rieth, Erin Campbell, Luke J Peppone, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Cancer|August 21, 2007
Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapyMichelle Shayne, Eva Culakova, Marek S Poniewierski, et al.
Cancer|August 13, 2009
Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapyMichelle Shayne, Eva Culakova, Debra Wolff, et al.
Journal of Geriatric Oncology|January 30, 2014
Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignanciesMichelle Shayne, Eva Culakova, Marek S Poniewierski, et al.
Frontiers in Nutrition|April 5, 2024
Changes in the consumption of isoflavones, omega-6, and omega-3 fatty acids in women with metastatic breast cancer adopting a whole-food, plant-based diet: post-hoc analysis of nutrient intake data from an 8-week randomized controlled trialJean Lee, Erin K Campbell, Eva Culakova, et al.
Pharmacoeconomics|April 4, 2007
Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspectiveLeon E Cosler, Adi Eldar-Lissai, Eva Culakova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2008
Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practiceJeffrey Crawford, David C Dale, Nicole M Kuderer, et al.
Journal of Geriatric Oncology|November 26, 2024
Designing observational studies to estimate treatment effects in geriatric oncology: A closer look at confounding and its mitigationNienke A de Glas, Sophie Pilleron, Esther Bastiaannet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic reviewGary H Lyman, David C Dale, Debra A Wolff, et al.
Cancer|April 22, 2011
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapyGary H Lyman, Nicole M Kuderer, Jeffrey Crawford, et al.
The Oncologist|September 20, 2025
Effect of a whole food plant-based dietary intervention on cancer progression and inflammatory markersKatherine K S Rieth, Erin Campbell, Luke J Peppone, et al.
Pageof 14